ACC

This channel contains news about the American College of Cardiology (ACC), including coverage of its annual meeting and links to recently released practice guidelines. The ACC is a leading resource for cardiology professionals, including all its subspecialties.

News | Cardiovascular Clinical Studies

Tricuspid Valve Repair System Shows Promising Results at One-year Follow-up

April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who ...

April 07, 2022

News | Structural Heart

No Reduction in Stroke, Mini Strokes, Blood Clotting in the Brain or Changes in Cognitive Function with Edoxaban After TAVR

April 7, 2022 – Patients treated with the blood thinner edoxaban for six months after a heart valve replacement ...

April 07, 2022

The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports continuing improvements in quality care delivery for heart attacks in low- and middle-income countries with the use of data collection and localized education around guideline-directed medical therapy, according to data from the program’s second year.

News | STEMI

ACC Program sees Improvement in Global Heart Attack Care

April 7, 2022 – The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports continuing ...

April 07, 2022

Sponsored Content

An example of the new generation of inexpensive, wearable cardiac monitors. This is the Cardiac Insight Cardea Solo device. #ACC18

Blog | Cardiac Diagnostics

Movement Toward Simpler, Wearable Cardiac Monitoring

The show floors at the American College of Cardiology (ACC) 2018 meeting in March and at the Heart Rhythm Society (HRS) ...

May 10, 2018

News | Cardiovascular Clinical Studies

SLN360 Markedly Reduces Lipoprotein(a), an Important Cause of Heart Disease

April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density ...

April 06, 2022

Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of patients with non-ST segment elevation myocardial infarction (NSTEMI).

News | Implantable Cardiac Monitor (ICM)

Insertable Cardiac Monitors (ICM) and Remote Monitoring May Improve Outcomes for Post-Myocardial Infarction Patients, Study Demonstrates

April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of ...

April 06, 2022

Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were 25% lower in 2021 than in 2020, and no deaths occurred among patients who had been vaccinated against COVID-19, according to data presented at the American College of Cardiology’s 71st Annual Scientific Session.

News | STEMI

In-Hospital Deaths in STEMI Patients With COVID-19 Drop in 2021

April 6, 2022 – Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were ...

April 06, 2022

Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure (CHF) patients, announced results of a clinical study demonstrating the efficacy of its contact-free technology for the detection of pulmonary congestion at home.

News | Heart Failure

Study Demonstrates Efficacy of Contact-Free Tech for Pulmonary Congestion Detection at Home

April 6, 2022 – Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure ...

April 06, 2022

The American College of Cardiology's Evolving Practice of Cardiovascular Precision Medicine course on May 13, 2022 will feature an opening session that includes Geoffrey Ginsburg, MD, PhD and Joshua C. Denny, MD, MS.

News | Cardiovascular Education

ACC Course Provides Updates from NIH's All of Us Research Program

April 4, 2022 – The American College of Cardiology's Evolving Practice of Cardiovascular Precision Medicine course on ...

April 04, 2022

News | ACC

Esperion Announces Two NEXLETOL Data Presentations at ACC.22

April 4, 2022 – Esperion presented two new analyses from its clinical development program of bempedoic acid (NEXLETOL) ...

April 04, 2022

Significant VHD is commonly encountered in practice, more commonly with advancing age, among women, and identified more frequently in centers offering percutaneous mitral therapies.

News | ACC

egnite, Inc. Announces Data from the Largest Contemporary Analysis of Valvular Heart Disease Prevalence in the US

April 3, 2022 — egnite, Inc., an advanced technology digital health company focused on providing artificial intelligence ...

April 03, 2022

A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath, according to late-breaking research presented today at the American College of Cardiology (ACC) Scientific Session in Washington, D.C.

News | ACC

ACC22: Interim Findings Show Promise in Decreasing Shortness of Breath From Hypertrophic Cardiomyopathy

April 3, 2022 — A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath ...

April 03, 2022

Silence Therapeutics, a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today presented detailed results from its phase 1 APOLLO trial

News | Heart Failure

Silence Therapeutics Announces Detailed Results from SLN360 Phase 1 Study in High Lipoprotein(a) Presented in Late Breaker at ACC22

April 3, 2022 — Silence Therapeutics, a leader in the discovery, development and delivery of novel short interfering ...

April 03, 2022

Royal Philips, a global leader in health technology, today announced the launch of Ultrasound Workspace [OLK1] at the American College of Cardiology’s Annual Scientific Session & Expo (ACC 2022).

News | Cardiovascular Ultrasound

Philips Launches Ultrasound Workspace at ACC 2022

April 2, 2022 — Royal Philips, a global leader in health technology, today announced the launch of Ultrasound Workspace ...

April 02, 2022

Aidoc, a leading provider of healthcare AI solutions, announced that it received FDA 510(k) clearance for its triage and notification of pneumothorax on X-ray exams.

News | Artificial Intelligence

Aidoc Expands AI Service to X-ray, Receiving FDA 510(k) Clearance for Pneumothorax

April 2, 2022 — Aidoc, a leading provider of healthcare AI solutions, announced that it received FDA 510(k) clearance ...

April 02, 2022

New ACC/AHA/HFSA guideline redefines heart failure stages to focus on prevention, updates treatment options and emphasizes care coordination with a heart failure specialty team

News | Heart Failure

ACC, AHA, HFSA Issue Joint Heart Failure Guideline

April 1, 2022 — A new joint guideline published today from the American College of Cardiology, the American Heart ...

April 01, 2022